USD 2.51 billion
Neuropathic Pain Market Size, Share, Growth Analysis, By Type(Peripheral Neuropathy, Entrapment Neuropathy, Post Traumatic Neuropathy, Phantom Limb Pain), By Drug Class(Strawberry, apple, mango, mixed fruit blends), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), By Diagnosis & Treatment(Imaging, Blood Tests, Physical Examination, Medication), By End User(Hospital, Clinics, Research Organizations, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2215 |
Region:
Global |
Published Date: June, 2024
Pages:
219
|Tables:
157
|Figures:
78
Neuropathic Pain Market Insights
Neuropathic pain market size was valued at USD 2.51 billion in 2022 and is poised to grow from USD 2.63 billion in 2023 to USD 3.80 billion by 2031, growing at a CAGR of 4.72% in the forecast period (2024-2031).
The growing incidence of persistent illnesses such as diabetes and the ageing populace make contributions to the growing occurrence of neuropathic pain. Ongoing research and improvement sports cognizance on novel remedies and pharmaceutical interventions, driving innovation in the marketplace.
Additionally, the increasing recognition among healthcare specialists and patients concerning powerful neuropathic ache control further stimulates marketplace growth. The market is dynamic, with pharmaceutical groups continually introducing new capsules and treatment modalities to address the unmet medical wishes related to neuropathic ache.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Anticonvulsants
Fastest Growth
Topical Treatments
Growth Rate
4.72% CAGR
Global Neuropathic Pain Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Neuropathic Pain Market Segmental Analysis
The neuropathic pain market is segmented based on indication, drug class, end user, type, diagnosis & treatment, distribution channel, and region. By indication, the market is segmented into diabetic neuropathy, spinal stenosis, chemotherapy-induced peripheral neuropathy, and others. By drug class, the market is segmented into tricyclic antidepressants, opioids, capsaicin cream, steroids, and others. By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and others. Based on type, the market is segmented into peripheral neuropathy, entrapment neuropathy, post traumatic, neuropathy, phantom limb pain, post herpetic neuralgia (PHN), trigeminal neuralgia, others. Based on diagnosis & treatment, the market is segmented into imaging, blood tests, physical examination, medication, multimodal therapy, and others. Based on end user, the market is segmented into hospitals, clinics, research organizations, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Middle East, and Africa, and South America.
Analysis by Type
Given the increasing incidence of diabetes globally, diabetic neuropathy may maintain to dominate the neuropathic ache marketplace. The rising prevalence of diabetes, particularly in getting old populations, contributes considerably to neuropathic ache instances.
With improvements in cancer remedies leading to improved survival fees, extra patients go through chemotherapy. Consequently, chemotherapy-precipitated neuropathy is probably the fastest growing type due to the increasing population of cancer survivors and the associated neuropathic ache demanding situations.
Analysis by Drug type
Anticonvulsant drugs, together with pregabalin and gabapentin, are typically prescribed for neuropathic pain due to their effectiveness in modulating nerve signals. Their mounted use and endured research in growing new anticonvulsant medicinal drugs position this drug elegance as a capacity market dominator.
Topical remedies, together with patches and creams containing analgesic marketers, provide localized alleviation with doubtlessly fewer systemic facet results. As sufferers and healthcare carriers are searching for options to systemic medicinal drugs, the call for for progressive and effective topical treatments may additionally pressure this drug elegance to be the quickest growing.
Global Neuropathic Pain Market By Drug Class
To get detailed analysis on other segments, Request For Free Sample Report
Neuropathic Pain Market Regional Insights
North America, specially the US, has a properly-set up healthcare infrastructure, a high prevalence of situations main to neuropathic ache (which includes diabetes and cancer), and giant investments in research and improvement. These elements role North America as a capability dominant location in the neuropathic ache marketplace.
The Asia-Pacific region, together with nations such as China and India, has a huge and developing population, increasing healthcare expenditure, and a growing awareness of neuropathic ache conditions. As healthcare infrastructure improves and get right of entry to to advanced treatments increases, the Asia-Pacific place may additionally witness the fastest increase within the neuropathic pain market.
Global Neuropathic Pain Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Neuropathic Pain Market Dynamics
Drivers
Increasing Prevalence Of Chronic Diseases Such As Diabetes
- The increasing prevalence of chronic illnesses which include diabetes, most cancers, and neurological problems has led to a higher incidence of neuropathic ache instances globally. As the aging populace expands, the risk elements related to neuropathic pain elevate, further propelling market call for. Secondly, ongoing improvements in scientific studies and pharmaceutical innovation make a contribution to the development of novel tablets and cures mainly designed to cope with neuropathic ache, enhancing the remedy panorama.
Restraints
High Challenges Related To Diagnosis And The Subjective Nature Of Pain Assessment
- One of the primary market restraints is the demanding situations associated with diagnosis and the subjective nature of ache evaluation pose hurdles in appropriately figuring out and quantifying neuropathic ache, doubtlessly leading to underreporting or mismanagement. Secondly, the high prices related to advanced remedy alternatives and medicines may restrict accessibility, mainly in areas with restricted healthcare budgets.
Request Free Customization of this report to help us to meet your business objectives.
Neuropathic Pain Market Competitive Landscape
The competitive surroundings of the Neuropathic Pain market is dynamic and characterised through the energetic participation of pharmaceutical agencies, research agencies, and healthcare establishments. Key gamers in the marketplace have interaction in strategic projects including mergers and acquisitions, partnerships, and product tendencies to bolster their market positions. The development and commercialization of novel drugs and remedies for neuropathic pain make contributions to excessive opposition.
Top Player’s Company Profiles
- Grunenthal GmbH (Germany)
- Mallinckrodt Pharmaceuticals (United States)
- Pfizer Inc. (United States)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- GlaxoSmithKline plc (GSK) (United Kingdom)
- Cipla Inc. (InvaGen Pharmaceuticals Inc.) (India)
- Glenmark Pharmaceuticals (India)
- Centaur Pharmaceuticals (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Dr. Reddy's Laboratories Ltd. (India)
- Lupin Ltd. (India)
- Laurus Labs (India)
- Lannett Company, Inc. (United States)
- Astellas Pharma Inc. (Japan)
- Biogen Inc. (United States)
- Cirtec Medical Corporation (United States)
- Integer Holdings Corporation (United States)
- B. Braun SE (Germany)
- Medtronic plc (Ireland)
Recent Developments
- In February 2024, a study published in PNAS examined the selective activity of sigmoid 2 receptor (σ2R) or transmembrane protein 97 (TMEM97) ligands on murine neuropathic pain models. The research delved into their impact on nociceptive neurons and the underlying mechanism of action observed after 24 hours.
- In February 2024, Scilex Holding Company unveiled a significant initiative in collaboration with a prominent national pharmacy chain to distribute GLOPERBA® across the majority of their stores throughout the United States.
- In January 2024, Neuralace Medical, Inc., a trailblazer in pain management technology, proudly revealed the FDA clearance of its revolutionary product, Axon Therapy (mPNS), for addressing chronic Painful Diabetic Neuropathy (PDN). This momentous approval signifies the inaugural FDA clearance of a non-invasive, magnetic peripheral nerve stimulation (mPNS) treatment specifically for Painful Diabetic Neuropathy, providing a beacon of hope to the countless individuals enduring this incapacitating condition.
- In March 2022, Daiichi Sankyo Company, Limited received approval in Japan to change the indication of the analgesic “Tarlige Tablets” (mirogabalin besilate) from “peripheral neuropathic pain” to “neuropathic pain”.
Neuropathic Pain Key Market Trends
- Rising Emphasis On The Development Of Novel Treatment Modalities: The developing emphasis on the improvement of novel treatment modalities and pharmaceutical interventions, reflecting the dynamic nature of research and improvement sports within the area. Additionally, the expansion of telehealth offerings and virtual fitness solutions is influencing how neuropathic pain is diagnosed, monitored, and managed, presenting patients with extra available and personalized care alternatives.
Neuropathic Pain Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global Neuropathic Pain marketplace evaluation famous a dynamic marketplace with some of standout trends and problems. The marketplace is driven by way of the rising prevalence of continual diseases, which include diabetes and cancer, main to an improved occurrence of neuropathic ache. Ongoing pharmaceutical innovation and advancements in treatment options propel marketplace growth. However, challenges in accurate prognosis, excessive remedy expenses, and ability aspect outcomes constrain accessibility. Anticonvulsants and opioids dominate the product kinds, with North America main the nearby market because of superior healthcare infrastructure. Key marketplace trends encompass the development of novel treatment modalities, expanding telehealth services, and a growing recognition on patient-centric methods.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.51 billion |
| Market size value in 2031 | USD 3.80 billion |
| Growth Rate | 4.72% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Neuropathic Pain Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Neuropathic Pain Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Neuropathic Pain Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Neuropathic Pain Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Neuropathic Pain Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Neuropathic Pain Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
